Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-01 4:11 pm Purchase |
2024-04-25 | 13G | Travere Therapeutics, Inc. TVTX |
Rock Springs Capital Management LP | 4,411,983 5.790% |
4,411,983 (New Position) |
Filing History |
| 2024-02-14 2:35 pm Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ARMISTICE CAPITAL LLC | 7,384,000 9.830% |
972,000 (+15.16%) |
Filing History |
| 2024-02-14 08:58 am Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 7,522,281 9.990% |
2,940,281 (+64.17%) |
Filing History |
| 2024-02-14 06:38 am Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
MACQUARIE GROUP LTD | 4,746,144 6.310% |
1,190,152 (+33.47%) |
Filing History |
| 2024-02-13 5:16 pm Purchase |
2023-12-29 | 13G | Travere Therapeutics, Inc. TVTX |
The Vanguard Group | 5,515,143 7.340% |
1,999,697 (+56.88%) |
Filing History |
| 2024-02-12 2:58 pm Sale |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
JANUS HENDERSON GROUP PLC JHG |
32,180 0.000% |
-5,059,105 (-99.37%) |
Filing History |
| 2024-02-09 10:33 am Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
MORGAN STANLEY MS |
4,152,446 5.500% |
4,152,446 (New Position) |
Filing History |
| 2024-02-07 07:37 am Sale |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 500,000 0.670% |
-3,918,962 (-88.69%) |
Filing History |
| 2024-01-25 09:24 am Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
STATE STREET CORP STT |
5,352,345 7.120% |
1,128,321 (+26.71%) |
Filing History |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
BlackRock Inc. BLK |
7,990,020 10.600% |
287,792 (+3.74%) |
Filing History |
| 2023-10-06 2:34 pm Purchase |
2023-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
BlackRock Inc. BLK |
7,702,228 10.300% |
2,507,443 (+48.27%) |
Filing History |
| 2023-05-15 5:02 pm Sale |
2023-05-15 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 0 0.000% |
-3,984,681 (Position Closed) |
Filing History |
| 2023-03-13 4:30 pm Purchase |
2023-03-01 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 4,418,962 5.940% |
1,818,962 (+69.96%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 3,984,681 6.200% |
-1,629,747 (-29.03%) |
Filing History |
| 2023-02-14 3:22 pm Sale |
2022-12-30 | 13G | Travere Therapeutics, Inc. TVTX |
MACQUARIE GROUP LTD | 3,555,992 5.540% |
-211,900 (-5.62%) |
Filing History |
| 2023-02-14 1:39 pm Purchase |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ARMISTICE CAPITAL LLC | 6,412,000 9.990% |
2,334,000 (+57.23%) |
Filing History |
| 2023-02-14 08:59 am Purchase |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 4,582,000 7.140% |
1,146,800 (+33.38%) |
Filing History |
| 2023-02-10 5:27 pm Sale |
2022-12-30 | 13G | Travere Therapeutics, Inc. TVTX |
GOLDMAN SACHS GROUP INC GS |
3,142,175 4.900% |
-1,457,104 (-31.68%) |
Filing History |
| 2023-02-10 11:50 am Purchase |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
JANUS HENDERSON GROUP PLC JHG |
5,091,285 7.900% |
1,075,127 (+26.77%) |
Filing History |
| 2023-02-09 11:35 am Sale |
2022-12-30 | 13G | Travere Therapeutics, Inc. TVTX |
The Vanguard Group | 3,515,446 5.480% |
-365,427 (-9.42%) |
Filing History |